Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 11:14:1214479.
doi: 10.3389/fendo.2023.1214479. eCollection 2023.

Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment

João Sérgio Neves  1   2 , Martin Buysschaert  3 , Michael Bergman  4
Affiliations
Editorial

Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment

João Sérgio Neves et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: cardiovascular disease; impaired fasting glucose; impaired glucose tolerance; microvascular complications; prediabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The Evolving Landscape of Prediabetes – Diagnosis, Complications, and Treatment Opportunities. Current knowledge and unmet needs. Underlined text highlights contributions made by articles published in the special topic “Prediabetes: New Insights on Diagnosis, Risk Stratification, Comorbidities, Cardiovascular Disease, Microvascular Complications, and Treatment”. eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; GLP-1 RA, GLP-1 receptor agonists; HFrEF, heart failure with reduced ejection fraction; OGTT, oral glucose tolerance test; SGLT2i, SGLT2 inhibitors.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment

References

    1. Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. . Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement. Jama (2021) 326(8):736–43. doi: 10.1001/jama.2021.12531 - DOI - PubMed
    1. Eades CE, France EF, Evans JM. Prevalence of impaired glucose regulation in Europe: a meta-analysis. Eur J Public Health (2016) 26(4):699–706. doi: 10.1093/eurpub/ckw085 - DOI - PubMed
    1. Neves JS, Newman C, Bostrom JA, Buysschaert M, Newman JD, Medina JL, et al. . Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes. Diabetes Res Clin Pract (2022) 190:109980. doi: 10.1016/j.diabres.2022.109980 - DOI - PubMed
    1. Gujral UP, Jagannathan R, He S, Huang M, Staimez LR, Wei J, et al. . Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis. BMJ Open Diabetes Res Care (2021) 9(1). doi: 10.1136/bmjdrc-2020-001776 - DOI - PMC - PubMed
    1. Kuro OM. Phosphate and klotho. Kidney Int (2011) 79121:S20–3. doi: 10.1038/ki.2011.26 - DOI - PubMed

Publication types

MeSH terms